A Close Look at Blinking After Facial Transplantation
Careful Planning and Monitoring Essential to Restore Blinking Function, Says Study in Plastic and Reconstructive Surgery
Recovery of blinking function is a critical but easily overlooked outcome after facial transplantation, according to a report in the January issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
In their study, ASPS member surgeon Eduardo DeJesus Rodriguez, MD, DDS, and colleagues highlight the need for careful surgical planning and technique to achieve optimal voluntary and reflex blinking—essential to protect long-term visual outcomes—in facial transplant recipients. Dr. Rodriguez is chair of the Department of Plastic Surgery at NYU Langone Medical Center and director of its Institute for Reconstructive Plastic Surgery.
Blinking Function Restored after Facial Transplantation
The study included detailed assessments of blinking function in a patient who underwent "facial vascularized composite tissue allotransplantation" after a devastating injury to the central and lower face caused by an accidental gunshot. The operation was one of the most extensive facial transplants to date, including "total face, double jaw, and tongue transplantation." The facial transplant was performed in March, 2012, when Dr. Rodriguez was at the University of Maryland Medical Center in Baltimore.
Vision and blinking function were evaluated before facial transplantation and up to several months afterward. Assessments included slow-motion video analysis of blinking—particularly involuntary or "reflex" blinking, which is essential to protect the eye.
Before transplantation, the patient had 100 percent voluntary blinking function (complete eyelid closure) in both eyes. But reflex blinking was significantly impaired immediately following the surgery, with only 40 percent reflex blinking on the right side. On the left side, the patient had 90 percent reflex blinking function.
Six months following the transplantation, visual acuity and eye movement remained normal on both sides. Meanwhile, involuntary reflex blinking improved substantially: 70 percent in the right eye and 100 percent in the left eye.
Call for Increased Attention to Periorbital Planning and Follow-up
Vision and blinking function again decreased as the patient went through a series of revision surgeries to improve functioning and appearance in the months after transplantation. These issues likely resulted from nerve injury (neuropraxia) caused by tissue handling during surgery. Both vision and blinking recovered over several weeks after these procedures.
Facial transplantation is still a rare procedure, but experience has shown excellent outcomes for carefully selected patients with severe facial injuries. Although blinking is easily overlooked, it is a complex facial function that is critical to protecting vision. At least some facial transplant recipients have experienced severe eyelid-related complications.
The study provides important information on recovery of blinking, especially reflex blinking, after facial transplantation. Dr. Rodriguez and colleagues believe their successful results reflect careful preservation of periorbital tissues from both the recipient and donor, followed by ingrowth of critical facial nerves. They encourage other facial transplant groups to perform similar evaluations of blinking function.
The effort to monitor restoration of blinking ability is an example of refinements to improve the long-term outcomes of facial transplantation, according to this month's introductory video by Rod J. Rohrich, MD, Editor-in-Chief, on the Plastic and Reconstructive Surgery website. "The fact that we are now researching blinking outcomes for these patients when face transplantation likely seemed more science fiction than science just a decade ago, shows how dedicated plastic and reconstructive surgeons around the globe have been in developing and refining this amazing, life-changing procedure," Dr Rohrich comments. Watch the accompanying Hot Topics in Plastic Surgery Video.
Plastic and Reconstructive Surgery® is published by Lippincott Williams & Wilkins, part of Wolters Kluwer Health.
About Plastic and Reconstructive Surgery
For more than 70 years, Plastic and Reconstructive Surgery® has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair, and cosmetic surgery, as well as news on medico-legal issues.
The American Society of Plastic Surgeons (ASPS) is the world's largest organization of board-certified plastic surgeons. Representing more than 8,000 Member Surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 93 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.